Clinical Trial

Financial Toxicity in Patients With Resected Soft Tissue and Bone Sarcomas

Recruiting
View on ClinicalTrials.gov →
Summary
To learn about the financial stress patients undergoing surgery to treat orthopedic cancer experience because of the costs of cancer care, and to learn about the effects of financial stress on participants quality of life.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-10-09.
Trial Details
NCT Number NCT07215611
Lead Sponsor M.D. Anderson Cancer Center
Conditions Bone Sarcomas, Financial Toxicity
Enrollment 100 participants
Start Date 2025-09-02
Primary Completion 2028-10-02 (estimated)
Study Completion 2030-10-02 (estimated)
Updated on ClinicalTrials.gov 2026-04-30